β-arrestin-biased parathyroid hormone ligands: A new approach to the development of agents that stimulate bone formation

Science Translational Medicine

Volumn 1, Issue 1, 2009, Pages

  Ferrari, Serge L ^a   Bouxsein, Mary L ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN; LIGAND; PARATHYROID HORMONE; RETINA S ANTIGEN;

ANIMAL; ARTICLE; BONE DEVELOPMENT; DRUG EFFECT; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; MOUSE; SIGNAL TRANSDUCTION;

ANIMALS; ARRESTINS; BONE DEVELOPMENT; FEMALE; HUMANS; LIGANDS; MALE; MICE; PARATHYROID HORMONE; SIGNAL TRANSDUCTION;

EID: 77954672681     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3000268     Document Type: Review

References (19)

1. D. Gesty-Palmer et al., A β-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation. Sci. Transl. Med. 1, 1ra1 (2009).
2. J. C. Huang et al., PTH diff erentially regulates expression of RANKL and OPG. J. Bone Miner. Res. 19, 235-244 (2004).
3. D. Goltzman, Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone. Arch. Biochem. Biophys. 473, 218-224 (2008).
4. H. Keller, M. Kneissel, SOST is a target gene for PTH in bone. Bone 37, 148-158 (2005).
5. R. M. Neer et al., Eff ect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N. Engl. J. Med. 344, 1434-1441 (2001).
6. D. W. Dempster et al., On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 84, 1562-1566 (1999).
7. L. M. Calvi et al., Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells diff erentially aff ects cortical and trabecular bone. J. Clin. Invest. 107, 277-286 (2001).
8. S. L. Ferrari, V. Behar, M. Chorev, M. Rosenblatt, A. Bisello, Endocytosis of ligand-human parathyroid hormone receptor 1 complexes is protein kinase C-dependent and involves β-arrestin2. Real-time monitoring by fluorescence microscopy. J. Biol. Chem. 274, 29968-29975 (1999).
9. S. L. Ferrari, A. Bisello, Cellular distribution of constitutively active mutant parathyroid hormone (PTH)/PTHrelated protein receptors and regulation of cyclic adenosine 3′,5′-monophosphate signaling by β-arrestin2. Mol. Endocrinol. 15, 149-163 (2001).
10. A. Bisello et al., Selective ligand-induced stabilization of active and desensitized parathyroid hormone type 1 receptor conformations. J. Biol. Chem. 277, 38524-38530 (2002).
11. E. N. Bianchi, S. L. Ferrari, β-arrestin2 regulates parathyroid hormone eff ects on a p38 MAPK and NFkappaB gene expression network in osteoblasts. Bone 45, 716-725 (2009).
12. D. D. Pierroz et al., β-arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice. J. Bone Miner. Res. 24, 775-784 (2009).
13. S. L. Ferrari et al., Bone response to intermittent parathyroid hormone is altered in mice null for β-arrestin2. Endocrinology 146, 1854-1862 (2005).
14. M. L. Bouxsein et al., β-arrestin2 regulates the diff erential response of cortical and trabecular bone to intermittent PTH in female mice. J. Bone Miner. Res. 20, 635-643 (2005).
15. A. Rey, D. Manen, R. Rizzoli, J. Caverzasio, S. L. Ferrari, Proline-rich motifs in the parathyroid hormone (PTH)/PTH-related protein receptor C terminus mediate scaffolding of c-Src with â-arrestin2 for ERK1/2 activation. J. Biol. Chem. 281, 38181-38188 (2006).
16. D. Gesty-Palmer et al., Distinct β-arrestin- and G protein-dependent pathways for parathyroid hormone receptorstimulated ERK1/2 activation. J. Biol. Chem. 281, 10856-10864 (2006).
17. A. Rey, D. Manen, R. Rizzoli, S. L. Ferrari, J. Caverzasio, Evidences for a role of p38 MAP kinase in the stimulation of alkaline phosphatase and matrix mineralization induced by parathyroid hormone in osteoblastic cells. Bone 41, 59-67 (2007).
18. J. D. Violin, R. J. Lefkowitz, β-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol. Sci. 28, 416-422 (2007).
19. P. J. Kostenuik et al., Infrequent delivery of a long-acting PTH-Fc fusion protein has potent anabolic eff ects on cortical and cancellous bone. J. Bone Miner. Res. 22, 1534-1547 (2007).